(EMAILWIRE.COM, November 17, 2008 ) – Jericho, N.Y. – MNI Nutraceuticals, Inc. (OTC:MNIA) is pleased to announce that it has received a second purchase order from the well known regional and on-line vitamin supplements retailer, The Vitamin Guy.
The Vitamin Guy carries innovative and cutting edge supplements, that cater to all aspects of nutrition and healthcare. The Vitamin Guy has submitted a Purchase Order to acquire NI Nutraceuticals Vital Slim product, an innovative weight loss, control and management product. http://www.vitaminguy.com.
Harvey Panesar, MNI Pharmaceuticals President stated,"We are absolutely pleased that The Vitamin Guy has provided us with a purchase order for the Vital Slim. The Vitamin Guy is known to be very aggressive in its marketing of its nutritional and healthcare products, through their very educated and informed staff. We are very excited that The Vitamin Guy will be offering our weight control product to their valued clientele.”
Smallcapnewsrelease Best Performing Stocks are Amgen, Inc. (NASDAQ: AMGN); Cephalon, Inc. (NASDAQ: CEPH); Teva Pharmaceutical Ind. (NASDAQ: TEVA); Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR); Alpharma, Inc. (NYSE: ALO); APP Pharmaceuticals, Inc. (NASDAQ: APPX); Barr Pharmaceuticals, Inc. (NYSE: BRL); and Cadence Pharmaceuticals, Inc. (NASDAQ: CADX)
Smallcapnewsrelease Worst Performing Stocks are NexMed, Inc. (NASDAQ: NEXM); Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI); Rexahn Pharmaceuticals, Inc. (AMEX: RNN); Tongjitang Chinese Med Co. (NYSE: TCM); Athersys, Inc. (NASDAQ: ATHX); Abbott Laboratories (NYSE: ABT); Eli Lilly and Co. (NYSE: LLY).
About MNI Nutraceuticals Inc.
MNI Nutraceuticals Inc. is a company focused on providing a better health and lifestyle through natural products. MNI Nutraceuticals flagship products include Arthrizyme(TM) for general joint pain and Vital Slim, which is a proprietary formula for weight control and management. http://www.martinnutra.com.
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid Smallcapnewsrelease $2,495.00 for the publication of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.
